Gilead Q3 Adjusted Earnings, Revenue Rise; Updates Guidance

04:13 PM EDT, 10/29/2026 (MT Newswires) -- Gilead Sciences (GILD) reported Q3 adjusted earnings late Thursday of $2.55 per diluted share, compared with $2.47 a year earlier. Analysts polled by FactSet expected $2.19. Revenue for the quarter ended Sept. 30 was $8.30 billion, compared with $7.77 billion a year ago. Analysts expected $7.81 billion. Gilead said it now expects 2026 adjusted loss per share of $1.20 to $0.85, compared with loss of $0.65 to $0.30 previously Analysts expected a loss of $0.40. It expects product sales of $31.00 billion to $31.30 billion, compared with $30.10 billion to $30.40 billion previously.